Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 12376210)

Published in Eur J Cancer on October 01, 2002

Authors

J M de Rijke1, H W H M van der Putten, L C H W Lutgens, A C Voogd, R F P M Kruitwagen, J A A M van Dijck, L J Schouten

Author Affiliations

1: Maastricht Cancer Registry, Comprehensive Cancer Centre Limburg, (IKL), PO Box 2208, The Netherlands. m.derijke@ikl.nl

Articles by these authors

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet (2010) 4.53

Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet (1994) 4.38

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15

Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97

Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol (1990) 2.69

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer (2008) 2.62

A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol (1999) 2.36

Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15

Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer. Ann Oncol (2012) 2.06

On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control (2007) 1.93

Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93

Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer (2004) 1.85

Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst (2010) 1.78

Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol (1996) 1.76

Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol (2003) 1.69

The joint association of air pollution and noise from road traffic with cardiovascular mortality in a cohort study. Occup Environ Med (2008) 1.63

Implementation of a short-stay programme after breast cancer surgery. Br J Surg (2010) 1.54

The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer (2001) 1.53

[Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period 1990-2002]. Ned Tijdschr Geneeskd (2005) 1.50

Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study. Ann Oncol (2012) 1.49

Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer (2004) 1.48

[Trends in the incidence and death from cancer from 1989-2003 in The Netherlands]. Ned Tijdschr Geneeskd (2006) 1.42

Presence of symptoms and timing of surgery do not affect the prognosis of patients with primary metastatic breast cancer. Eur J Surg Oncol (2011) 1.40

Do patients prefer mesh or anterior colporrhaphy for primary correction of anterior vaginal wall prolapse: a labelled discrete choice experiment. BJOG (2014) 1.39

Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol (2003) 1.38

Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut (2010) 1.38

Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32

Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26

Epidemiology and treatment of extramammary Paget disease in the Netherlands. Eur J Surg Oncol (2007) 1.24

The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study. Gynecol Oncol (2005) 1.21

Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer (2001) 1.19

Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer (2011) 1.18

A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer (2006) 1.17

Clinical epidemiology of breast cancer in the elderly. Eur J Cancer (2007) 1.17

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer (1999) 1.17

Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival. Breast Cancer Res Treat (2011) 1.16

Cancer in the very elderly Dutch population. Cancer (2000) 1.12

Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer (1995) 1.12

Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol (2009) 1.12

Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol (2008) 1.11

Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer (1993) 1.09

Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer (2006) 1.09

Screening for second primary melanomas: is it efficient? Br J Dermatol (2013) 1.07

Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations--no definite conclusions. Int J Hyperthermia (2002) 1.07

Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg (2012) 1.06

Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer (2003) 1.04

The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (2005) 1.02

Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study. Am J Epidemiol (2010) 0.99

The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol (2005) 0.99

Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat (2006) 0.99

Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol (2012) 0.99

The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era. Ann Surg Oncol (2014) 0.99

Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients. Eur J Cancer (2013) 0.98

Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant (2004) 0.98

Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97

Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer (2003) 0.97

Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat (2008) 0.97

Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer (2004) 0.95

Sentinel lymph node biopsy to direct treatment in gastric cancer. A systematic review of the literature. Eur J Surg Oncol (2011) 0.95

Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer (2006) 0.95

Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut (2006) 0.95

Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands. Breast Cancer Res Treat (2011) 0.94

A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Ann Oncol (2013) 0.93

The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer (2013) 0.93

Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer (2006) 0.92

Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial. Eur J Cancer (2011) 0.92

Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys (1999) 0.91

Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast (2009) 0.91

Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer (2007) 0.91

Genetic susceptibility to sporadic ovarian cancer: a systematic review. Biochim Biophys Acta (2011) 0.91

Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol (2006) 0.91

Prognostic factors for survival in metastatic breast cancer by hormone receptor status. Breast Cancer Res Treat (2014) 0.88

Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol (2011) 0.87

Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma. Br J Cancer (2006) 0.87

A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands. J Med Screen (2000) 0.86

Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat (2008) 0.86

Trends in surgery for screen-detected and interval breast cancers in a national screening programme. Br J Surg (2014) 0.85

Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol (1999) 0.84

The Neuro-Oncology Register. Neuroepidemiology (1992) 0.84

A systematic review of the relation between interleukin-2 schedule and outcome in patients with metastatic renal cell cancer. Eur J Cancer (2004) 0.84

[Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995]. Ned Tijdschr Geneeskd (2000) 0.83

False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol (1995) 0.83

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands. Breast Cancer Res Treat (2011) 0.83

Prevalence of lymphoedema more than five years after breast cancer treatment. Eur J Surg Oncol (2011) 0.83

Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001. Breast (2007) 0.83

Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands. Breast Cancer Res Treat (2013) 0.83

Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer. Int J Gynecol Cancer (2007) 0.83

Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur J Surg Oncol (2006) 0.82

Reliability of receptor assessment on core needle biopsy in breast cancer patients. Tumour Biol (2012) 0.82

Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands. Ann Surg Oncol (2014) 0.82

Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review. Cancer Imaging (2013) 0.82

Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up. Breast (2001) 0.82

Factors influencing participation among melanoma screening attenders. Acta Derm Venereol (1997) 0.82

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer. Br J Cancer (2003) 0.82

Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits? Eur J Cancer (2007) 0.82

[Breast cancer in young women: epidemiology and treatment dilemmas]. Ned Tijdschr Geneeskd (2008) 0.82

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer (2012) 0.82